BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 15, 2007
View Archived Issues
Phase III data on difluprednate ophthalmic emulsion in ophthalmic conditions
Read More
HDAC inhibition restores learning and memory in a mouse model of neurodegeneration
Read More
Long-term inhibition of choroidal neovascularization with engineered ZFP transcription factor
Read More
Safety established for SNJ-1656 in the treatment of glaucoma
Read More
Phase I/II trial cleared for CAM-2032 leuprolide depot
Read More
Nippon Shinyaku resolves joint development agreement for TRK-091
Read More
AERAS-402 studied for TB in new South African study
Read More
Phase I trial planned for CALAA-01 in advanced solid tumors
Read More
BF-37 enters phase II study in atopic dermatitis
Read More
NCI seeks FDA approval to study Oncolytics' Reolysin in phase II for melanoma
Read More
GlaxoSmithKline returns rights to Futura for MED-2002 for ED
Read More
Study of dextromethorphan in involuntary emotional expression disorder advances / News in Context
Read More
Study reveals potential of alemtuzumab in sporadic inclusion body myositis
Read More
PTC-124 active in Duchenne muscular dystrophy due to a nonsense mutation
Read More
Long-term suppression of chorea seen with tetrabenazine in Huntington's disease
Read More
New antithrombotic agents disclosed in recent Toray patent
Read More
Recent patents divulge novel analgesic agents
Read More
Novel opioid receptor antagonists emerge from Adolor R&D
Read More
Recent Chugai and sanofi-aventis patents describe new treatment options for diabetes
Read More
FDA approves first nebulized formoterol fumarate for emphysema and COPD
Read More
FDA approves Fosamax Plus D with higher vitamin D content
Read More
Wyeth Pharmaceuticals seeks EMEA approval of subcutaneous methylnaltrexone
Read More
